SCHEMBL347307

SCHEMBL347307

O=Cc1cnc(C(F)(F)F)nc1

nearest known ligand 0.38

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.38
POLB P06746 1/20 0.38
KIF11 P52732 1/20 0.32
KDM4E B2RXH2 1/20 0.31
KCNJ1 P48048 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7981986 0.84 ALDH1A1 (0.37) ALDH1A1L3MBTL1POLBKIF11KDM4E
SCHEMBL16461464 0.82 ALDH1A1 (0.33) ALDH1A1L3MBTL1POLBKDM4E
SCHEMBL7996334 0.82 ALDH1A1 (0.33) ALDH1A1L3MBTL1POLB
SCHEMBL27963643 0.81 FOS (0.30)
SCHEMBL6225863 0.79 ALDH1A1 (0.39) ALDH1A1KDM4E
SCHEMBL6225865 0.79 ALDH1A1 (0.39) ALDH1A1KDM4E
SCHEMBL25223884 0.77 VNN1 (0.32)
SCHEMBL1120452 0.76 ALDH1A1 (0.33) ALDH1A1
SCHEMBL25402026 0.76 TRPV3 (0.30)
SCHEMBL7439427 0.76 ALDH1A1 (0.37) ALDH1A1L3MBTL1KDM4EKCNJ1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 261 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509439-B2 Anti-malarial agents UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2025-12-30 US disclosed
US-12497399-B2 Fluorinated integrin antagonists OCUTERRA THERAPEUTICS, INC. (US) 2025-12-16 US disclosed
US-20250368625-A1 PIPERAZINES Grünenthal GmbH (DE) 2025-12-04 US disclosed
US-12297197-B2 Pyrazolopyridine compound as RET inhibitor and application thereof GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS CO., LTD. BAIYUNSHAN PHARMACEUTICAL GENERAL FACTORY (CN) 2025-05-13 US disclosed
US-12286432-B2 Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof OCUTERRA THERAPEUTICS, INC. (US) 2025-04-29 US disclosed
CN-115380027-B Novel antimalarial agents 肯塔基大学研究基金会 2024-10-18 CN disclosed
WO-2024175026-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICAL USE THEREOF 哈尔滨三联药业股份有限公司 2024-08-29 WO disclosed
CN-118546109-A Nitrogen-containing heterocyclic compound and medical application thereof 哈尔滨三联药业股份有限公司 2024-08-27 CN disclosed
US-20240246932-A1 ARYL 3-OXOPIPERAZINE CARBOXAMIDES AND HETEROARYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS MERCK SHARP & DOHME LLC (US) 2024-07-25 US disclosed
US-20240140942-A1 FLUORINATED INTEGRIN ANTAGONISTS FELIQS CORPORATION (JP) 2024-05-02 US disclosed
US-5750704-A INSECTICIDES NIHON BAYER AGROCHEM K.K. (JP) 1998-05-12 US disclosed
US-5580889-A Insecticidal nitromethyl or niteoimino-heteromethyl-heterocyclics NIHON BAYER AGROCHEM K.K. (JP) 1996-12-03 US disclosed
US-5461167-A 2-chloro-5-chloromethyl thiazole; insecticide NIHON BAYER AGROCHEM K.K. (JP) 1995-10-24 US disclosed
US-5428032-A Insecticides NIHON BAYER AGROCHEM K.K. (JP) 1995-06-27 US disclosed
US-5298507-A Insecticides NIHON BAYER AGROCHEM K.K. (JP) 1994-03-29 US disclosed
US-5204360-A Insecticides NIHON BAYER AGROCHEM K.K. (JP) 1993-04-20 US disclosed
US-5001138-A Insecticides NIHON TOKUSHU NOYAKU SEIZO, K.K. (JP) 1991-03-19 US disclosed
US-4845106-A INSECTICIDES NIHON TOKUSHU NOYAKU SEIZO K.K. (JP) 1989-07-04 US disclosed
US-4742060-A 2-(NITROIMINO)- OR 2-(NITROMETHYLENE)-IMIDAZOLIDINES AS INSECTICIDES NIHON TOKUSHU NOYAKU SEIZO K. K. (JP) 1988-05-03 US disclosed
EP-0192060-A1 Heterocyclic compounds NIHON BAYER AGROCHEM K.K. (JP) 1986-08-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12297197-B2 Pyrazolopyridine compound as RET inhibitor and application thereof RET, BRAF, RAF1 ALDH1A1 1309/4885L3MBTL1 4742/4885POLB 3427/4885
US-20240140942-A1 FLUORINATED INTEGRIN ANTAGONISTS ITGB5, ITGB1, ITGA5 ALDH1A1 2260/4885L3MBTL1 4764/4885POLB 4045/4885
US-20240246932-A1 ARYL 3-OXOPIPERAZINE CARBOXAMIDES AND HETEROARYL 3-OXOPIPERAZINE CARBOXAMIDES AS NAV1.8 INHIBITORS TRPV1, SCN8A, SCN2A ALDH1A1 2844/4885L3MBTL1 4098/4885POLB 4835/4885
US-12509439-B2 Anti-malarial agents RCC1, PFN1, NHERF1 ALDH1A1 1353/4885L3MBTL1 3793/4885POLB 3838/4885
US-12286432-B2 Fluorinated tetrahydronaphthyridinyl nonanoic acid derivatives and uses thereof FFAR3, FFAR2, FFAR1 ALDH1A1 1949/4885L3MBTL1 4681/4885POLB 4210/4885
US-12497399-B2 Fluorinated integrin antagonists ITGB5, ITGB1, ITGA5 ALDH1A1 2260/4885L3MBTL1 4764/4885POLB 4045/4885
US-20250368625-A1 PIPERAZINES SSTR4, SSTR5, SSTR2 ALDH1A1 2067/4885L3MBTL1 4881/4885POLB 4101/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.